Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection

Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection

Show other versions (1)

Bibliographic Details
Main Authors:	J. Porta-Etessam, M. Yus, N. González García, A. Valcarcel, J. Barrado-Cuchillo, J. Pérez-Somarriba
Format:	Article
Language:	Spanish
Published:	Elsevier España 2020-11-01
Series:	Neurología
Online Access:	http://www.sciencedirect.com/science/article/pii/S0213485320302449

Similar Items

Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection
by: J. Porta-Etessam, et al.
Published: (2020-11-01)

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
by: Nazzarena Labò, et al.
Published: (2020-06-01)

Paraneoplastic Syndrome and SARS-CoV-2—Incremental Effect of 2 Thrombogenic Conditions?Novel Teaching Points
by: Norman Mangner, MD, et al.
Published: (2021-02-01)

OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection
by: S. Santos-Lasaosa, et al.
Published: (2020-06-01)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
by: J. Matías-Guiu, et al.
Published: (2020-04-01)

Infiltración con onabotulinumtoxinA y bloqueos en el paciente con cefalea y neuralgia: recomendaciones de seguridad frente a la infección por SARS-CoV-2
by: S. Santos-Lasaosa, et al.
Published: (2020-06-01)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
by: Carlos A. Labarrere, et al.
Published: (2020-03-01)

¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
by: J. Matías-Guiu, et al.
Published: (2020-04-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

A blood analogue for thrombogenicity assessment
by: Lewis, J. M. O.
Published: (1981)

The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
by: Maria Manuela Estevinho, et al.
Published: (2020-05-01)

Indomethacin & SARS-CoV-2: Prospects for clinical management of the inflammatory state
by: Satyanath R. Kodidala, et al.
Published: (2021-12-01)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021-07-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
by: Bao, J., et al.
Published: (2021)

Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
by: María José Abenza-Abildúa, PhD, et al.
Published: (2020-09-01)

Interactions of SARS-CoV-2 with the Blood–Brain Barrier
by: Michelle A. Erickson, et al.
Published: (2021-03-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies
by: H. Guadalajara, et al.
Published: (2021-10-01)

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
by: Justin Fortune Creeden, et al.
Published: (2021-06-01)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
by: Alena Liskova, et al.
Published: (2021-06-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
by: Ritesh Gorkhali, et al.
Published: (2021-06-01)

Anti-thrombogenicity by Layer-by-Layer
by: Shiratori Seimei, et al.
Published: (2013-08-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
by: David L. Suarez, et al.
Published: (2020-12-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.
by: Priya V K, et al.
Published: (2021-01-01)

Traumatic Brain Injury during the SARS-CoV-2 Pandemic
Published: (2020-07-01)

Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection
by: Luana M. Manosso, et al.
Published: (2021-08-01)

Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
by: Isu, U.H, et al.
Published: (2022)

Multisistemic Pediatric Inflammatory Syndrome (PIMS) and the association with SARS-CoV-2
by: Eduardo Haruo Uchiya
Published: (2020-06-01)